Royal Bancshares of Pennsylvania, Inc. Announces

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
261
Royal Bancshares of Pennsylvania, Inc. Announces Shareholder Approval of Pending Merger with Bryn Mawr Bank Corporation

BALA CYNWYD, PA --(Marketwired - May 25, 2017) - Royal Bancshares of Pennsylvania, Inc. ("Royal") ( NASDAQ : RBPAA ), the holding company for Royal Bank America, announced that its shareholders approved its pending merger transaction with Bryn Mawr Bank Corporation (the "Corporation") at a special meeting of shareholders held on May 24, 2017. At the Special Meeting, 98.6% of votes cast were voted in favor of the merger.

"We were pleased to have such widespread approval from our shareholders for our strategic direction to merge with Bryn Mawr Trust," remarked President and CEO Kevin Tylus. As previously reported in required filings, a third quarter 2017 closing is anticipated, subject to receipt of required regulatory approvals and satisfaction of the remaining conditions set forth in the merger agreement.

About Royal Bancshares of Pennsylvania, Inc.

Royal Bancshares of Pennsylvania, Inc., headquartered in Bala Cynwyd, Pennsylvania, is the parent company of Royal Bank America, which is headquartered in Narberth, Pennsylvania. Royal Bank serves growing small and middle market businesses, commercial real estate investors, consumers, and depositors principally in Montgomery, Delaware, Chester, Bucks, Philadelphia and Berks counties in Pennsylvania, central and southern New Jersey, and Delaware. Established in 1963, Royal Bank provides an array of financial products and services through a comprehensive suite of cash management services and twelve branches and two loan production offices. More information on Royal Bancshares of Pennsylvania, Inc., Royal Bank America, and its subsidiaries can be found at www.royalbankamerica.com .

Forward-Looking Statements

The foregoing material may contain forward-looking statements. We caution that such statements may be subject to a number of uncertainties, and actual results could differ materially; therefore, readers should not place undue reliance on any forward-looking statements. Royal Bancshares of Pennsylvania, Inc. does not undertake, and specifically disclaims, any obligation to publicly release the results of any revisions that may be made to any forward-looking statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date of such statements. For a discussion of the factors that could cause actual results to differ from the results discussed in any such forward-looking statements, see the filings made by Royal Bancshares of Pennsylvania, Inc. with the Securities and Exchange Commission, including its Annual Report -- Form 10-K for the year ended December 31, 2016.

Such forward-looking statements involve known and unknown risks and uncertainties. A number of factors could cause actual results, events or developments, or industry results, to be materially different from any future results, events or developments expressed, implied or anticipated by such forward-looking statements, and so business and financial condition and results of operations could be materially and adversely affected. In addition to factors previously disclosed in the Corporation's and Royal's reports filed with the U.S. Securities and Exchange Commission (the "SEC") and those identified elsewhere in this document, such factors include, among others, that required regulatory, shareholder or other approvals are not obtained or other closing conditions are not satisfied in a timely manner or at all; that prior to the completion of the transaction or thereafter, the Corporation's and Royal's respective businesses may not perform as expected due to transaction-related uncertainty or other factors; that the parties are unable to successfully implement integration strategies; reputational risks and the reaction of the companies' customers to the transaction; diversion of management time on merger-related issues; the integration of acquired business with the Corporation may take longer than anticipated or be more costly to complete and that the anticipated benefits, including any anticipated cost savings or strategic gains may be significantly harder to achieve or take longer than anticipated or may not be achieved; the need for capital, ability to control operating costs and expenses, and to manage loan and lease delinquency rates; the credit risks of lending activities and overall quality of the composition of loan, lease and securities portfolio; the impact of economic conditions, consumer and business spending habits, and real estate market conditions ; changes in the levels of general interest rates, deposit interest rates, or net interest margin and funding sources; changes in banking regulations and policies; changes in accounting policies and practices; the inability of key third-party providers to perform their obligations to us; our ability to attract and retain key personnel; competition in our marketplace; war or terrorist activities. All forward-looking statements and information set forth herein are based on management's current beliefs and assumptions as of the date hereof and speak only as of the date they are made. The Corporation and Royal do not undertake to update forward-looking statements.

Contact Information Michael Thompson Executive Vice President and Chief Financial Officer mthompson@royalbankamerica.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Doximity's Legal Woes: Class Action Deadline Looms

Updated Category News Views 51

The Truth Behind Doximity's Promises The brass tacks of investing often boil down to trust—a commodity that's now in short supply over at Doximity, Inc. (NYSE: DOCS). Investors have been left hanging after promises of lucrative engagement signals turned out to be a mere pipe dream. Levi & Korsinsky, LLP sounds the alarm on what's shaping up to be a high-stakes class...

Continue Reading
DAN, GPRO, PSNL Deals Under Investor Scrutiny

Updated Category News Views 251

Behind the Curtain: What Do These Deals Mean for Shareholders? Sometimes, investing in a stock ain't just about numbers on a screen—it's about untangling the whole messy ball of yarn these companies hand you with a smile. We're looking at Dana Incorporated (NYSE: DAN), GoPro, Inc. (NASDAQ: GPRO), and Personalis, Inc. (NASDAQ: PSNL). They've all got deals on the table,...

Continue Reading
Fluence Energy Lawsuit: Investor Unrest Unleashed

Updated Category News Views 136

The Turbulence Behind FLNC: A Hard Pill to Swallow Looks like Fluence Energy (NASDAQ: FLNC) has stumbled right into a mess that's leaving investors with a bitter aftertaste. A securities class action lawsuit has been thrown their way, shaking up any stability folks thought they had. Levi & Korsinsky, LLP laid down the gauntlet on behalf of the shareholders hoodwinked by...

Continue Reading
Gilbert Welcomes Luxury Florals: French Florist Expands

Updated Category News Views 103

A Fresh Bloom in Gilbert: French Florist Steps In Toss aside your preconceived notions of what a florist shop should be. When French Florist sets up shop, it's not just about selling flowers—they’re a game-changer in the floral industry. As of November 4, they've stamped their luxury mark in Gilbert, Arizona, courtesy of Ronny and Nicole Record, who aren’t your...

Continue Reading
Parloa and OpenAI Expand AI Customer Service Partnership

Updated Category News Views 141

AI Agents: A New Frontier in Customer Service The world of customer service is about to see a major shake-up, folks. Parloa, with its roots deep in AI customer service innovation, and tech powerhouse OpenAI are teaming up to expand their partnership. This isn’t some pie-in-the-sky dream; this is about bringing real-life improvements to how businesses and customers...

Continue Reading
Madrigal Faces Troubling Whistleblower Claims

Updated Category News Views 69

Whistleblower Complaint Rocks Madrigal Let me tell you, today's chatter isn't for the faint-hearted investor. Madrigal Pharmaceuticals (NASDAQ: MDGL) is under scrutiny, and it's making waves. The gears started turning when their former Senior VP and Head of Clinical Development unloaded a bombshell: he reported dirt on Madrigal's safety and efficacy data for Rezdiffra,...

Continue Reading
Nektar Gears Up for Key November Investor Engagements

Updated Category News Views 66

Nektar Therapeutics on the Investor Radar Here's the scoop in the biotech world: Nektar Therapeutics, that clinical-stage biotech pioneer, is stepping into the spotlight at not one, but two heavyweight investor gigs this November. Showcasing their hand not just means they'll draw the curtains on their groundbreaking pipeline, but it's a shot across the bow to remind us...

Continue Reading
Clarivate's Upcoming Conference Presentation: What to Expect

Updated Category News Views 71

Conference Time: Will Clarivate Deliver the Goods? Grab your calendars, folks. November 18 is when Clarivate Plc is stepping into the spotlight at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference. Their bigwigs, Matti Shem Tov, the CEO, and Michael Easton, the CFO, will be there to spill the beans. They’re set to take the mike...

Continue Reading
MyyShop Poised to Redefine the Creator Economy

Updated Category News Views 101

Breaking Ground in Creator Ecosystems MyyShop isn't just a player in the creator economy; it's trying to change the damned rules. By focusing intensely on co-creation and learning, MyyShop's putting its chips on creating an inclusive and sustainable space where creators aren't just participants but the ones calling the shots. Catalyzing Co-Creation Everybody in the game...

Continue Reading
VTech's Revenue Jump: Profit Margins Slip Amid Cost Surge

Updated Category News Views 17

Charting VTech's Financial Waters Well, here we are – another chapter in the saga of VTech, the electronic learning product titan. This time, they've danced a jig of higher revenues, a sweet 5.6% jump to $1,046.9 million for the six months leading to September 2026. But hang on, the party's not all balloons and confetti. Profit margins? They're bobbing like a ship in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Assurant Stock Analysis: Navigating a 52-Week Low

Updated Category News Views 134

Assurant Stock Hits 52-Week Low In the midst of evolving market conditions, Assurant Inc. (NYSE: AIZ) has seen its stock price drop to a notable 52-week low of $19.85. This decline translates to a 1-year change of -2.2%, prompting investors to reassess their strategies. However, amid this downturn, Assurant continues to exhibit robust fundamentals, evidenced by its...

Continue Reading
Ona Therapeutics Boosts Leadership to Propel Innovative Cancer Treatments

Updated Category News Views 250

Ona Therapeutics Strengthens Leadership Team for Innovative Cancer Therapies Ona Therapeutics is making waves in the biotech industry with its recent strategic leadership appointments aimed at fast-tracking the development of innovative antibody-drug conjugates (ADCs). These ADCs are designed to target and destroy hard-to-treat cancer cells across various solid tumor...

Continue Reading
The Exciting Return of NJ Digital Marketing Conference 2025

Updated Category News Views 269

New Jersey Digital Marketing Conference is Back! Mark your calendars for the much-anticipated return of the New Jersey Digital Marketing Conference (NJDMC) on October 23, 2025, at the historic Bell Works campus. This vibrant event aims to unite innovative marketers, industry leaders, and creative thinkers for an inspiring day filled with learning and networking. A Day of...

Continue Reading
Hancock Health Partners with Revology for Enhanced Revenue Operations

Updated Category News Views 120

Hancock Health Partners with Revology for Enhanced Revenue Operations Hancock Health is excited to announce its partnership with Revology aimed at transforming its revenue cycle management (RCM) operations. This collaboration marks a significant step towards adopting advanced technology that promises to improve efficiency and transparency in the billing processes....

Continue Reading
Middlefield Canadian Income PCC: Insights on Share Value

Updated Category News Views 132

Middlefield Canadian Income PCC Overview Middlefield Canadian Income PCC, a respected entity in the financial sector, has been gaining attention among investors. This protected cell company, incorporated in Jersey with registration number 93546, operates under the legal entity identifier 2138007ENW3JEJXC8658. Known for its strategic investments, the company focuses on...

Continue Reading